Skip to main content

CONMED Corp

corporate_fare Company Profile

CONMED Corp

CNMD·NYSE·Industrial Applications And Services·CIK 0000816956

CONMED Corporation develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions for soft tissue injury augmentation and repair. Supporting orthopedic products include powered resection instruments, fluid management, and visualization systems, along with related single-use products for minimally invasive sports medicine surgeries. Under the Hall surgical brand, CONMED provides battery-powered, autoclavable, large, and small bone power tool systems for orthopedic, arthroscopic, oral/maxillofacial, podiatric, spinal, and cardiothoracic surgeries. The company's general surgery products include AirSeal brand clinical insufflation systems and Buffalo Filter brand smoke removal devices. Endomechanical products, such as the Anchor1 line of tissue retrieval bags, trocars, suction irrigation devices, graspers, scissors, and dissectors, are used in minimally invasive surgeries. Electrosurgical solutions comprise monopolar and bipolar generators, argon beam coagulation generators, handpieces, smoke management systems, and other accessories. CONMED also provides endoscopic technologies, including therapeutic and diagnostic products for gastroenterology procedures, and products to treat diseases of dilation, hemostasis, biliary, stricture management, and infection prevention. Patient monitoring products include ECG electrodes, EEG electrodes, and cardiac defibrillation pads. The company markets its products directly to hospitals, surgery centers, and other healthcare institutions, and through medical specialty distributors. CONMED Corporation was incorporated in 1970 and is headquartered in Largo, Florida.

CONMED Corp (NYSE:CNMD) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 18 items for CNMD at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-07-29, rated 7/10. Across its 18 most recent items scored 7 or higher, the top rating is 9/10, with 10 rated 8 or above. Recent SEC coverage for CNMD spans 10-Q, 8-K, DEF 14A, 10-K.

Recent high-impact activity:

  • CONMED Q2 GAAP EPS Up 11.6%, Details Convertible Note Repurchase & Strategic Divestiture
  • CONMED Beats Q2 Views, Raises EPS Guidance on Strong Organic Growth
  • FDA Clears CONMED's AirSeal for da Vinci 5 Hex Cannula, Expanding Robotic Surgery Reach
  • Conmed Weighs Sale After Receiving Takeover Interest
  • CONMED Appoints Experienced CFO John Gallagher from Certara, Strengthening Financial Leadership

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$1.37B
Net Income
$47.05M
Diluted EPS
$1.51
Op. Cash Flow
$170.69M
Free Cash Flow
$150.88M
Gross Profit
$750.48M
Operating Income
$102.62M
Cash & Equivalents
$40.82M
Debt / Equity
0.00×
Net Margin
3.4%
Shares Outstanding
31.04M sh
Source: 10-K · filed 2026-02-17 · accession 0000816956-26-000009

Short Interest & Short Volume

7.31 days to cover

FINRA reported short interest of 2,137,300 shares in CNMD as of the September 15, 2026 settlement, a 5.6% decrease from the prior period — about 7.3 days to cover at its recent average daily volume. On October 2, 2026, 61.6% of CNMD volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)2,137,300 shares as of September 15, 2026
Change vs prior period▼ 5.6%
Days to cover7.31 at avg daily volume of 292,435
Daily short volume (FINRA facilities)61.6% of 98,659 shares on October 2, 2026
5-day average short volume61.1%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$46.32
52-week range · as of 2026-07-29 $31.44 – $56.63
Market cap
$1.39B
Volume
240.7K (0.8× avg)
3-mo avg 313.4K
Live data · 2026-10-05 02:50 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CNMD - Latest Insights

CNMD
Jul 29, 2026, 4:13 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $46.45
Real-time Price: $46.32 info
Change: -$0.130 (-0.28%) info
Market Cap: $1.387B info
CNMD
Jul 29, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $43.21
Real-time Price: $46.32 info
Change: +$3.11 (+7%) info
Market Cap: $1.387B info
CNMD
Jul 22, 2026, 7:00 AM EDT
Source: BusinessWire
Importance Score:
7
Price at Filing: $42.20
Real-time Price: $46.32 info
Change: +$4.12 (+10%) info
Market Cap: $1.387B info
CNMD
Jul 10, 2026, 6:18 PM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $40.00
Real-time Price: $46.32 info
Change: +$6.32 (+16%) info
Market Cap: $1.387B info
CNMD
Jun 17, 2026, 4:49 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $32.11
Real-time Price: $46.32 info
Change: +$14.21 (+44%) info
Market Cap: $1.387B info
CNMD
Jun 04, 2026, 7:30 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $33.85
Real-time Price: $46.32 info
Change: +$12.47 (+37%) info
Market Cap: $1.387B info
CNMD
Jun 01, 2026, 8:33 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $35.70
Real-time Price: $46.32 info
Change: +$10.62 (+30%) info
Market Cap: $1.387B info
CNMD
Jun 01, 2026, 8:31 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.70
Real-time Price: $46.32 info
Change: +$10.62 (+30%) info
Market Cap: $1.387B info
CNMD
May 20, 2026, 8:30 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $36.18
Real-time Price: $46.32 info
Change: +$10.14 (+28%) info
Market Cap: $1.387B info
CNMD
Apr 30, 2026, 9:52 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $38.67
Real-time Price: $46.32 info
Change: +$7.65 (+20%) info
Market Cap: $1.387B info
CNMD
Apr 29, 2026, 4:34 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $35.96
Real-time Price: $46.32 info
Change: +$10.36 (+29%) info
Market Cap: $1.387B info
CNMD
Apr 29, 2026, 4:18 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.96
Real-time Price: $46.32 info
Change: +$10.36 (+29%) info
Market Cap: $1.387B info
CNMD
Apr 07, 2026, 8:23 AM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $34.08
Real-time Price: $46.32 info
Change: +$12.24 (+36%) info
Market Cap: $1.387B info
CNMD
Mar 13, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $37.28
Real-time Price: $46.32 info
Change: +$9.04 (+24%) info
Market Cap: $1.387B info
CNMD
Feb 17, 2026, 11:01 AM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $41.94
Real-time Price: $46.32 info
Change: +$4.38 (+10%) info
Market Cap: $1.387B info
CNMD
Jan 28, 2026, 4:13 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $39.68
Real-time Price: $46.32 info
Change: +$6.64 (+17%) info
Market Cap: $1.387B info
CNMD
Jan 12, 2026, 9:00 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $42.91
Real-time Price: $46.32 info
Change: +$3.41 (+8%) info
Market Cap: $1.387B info
CNMD
Jan 08, 2026, 5:00 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $44.20
Real-time Price: $46.32 info
Change: +$2.12 (+5%) info
Market Cap: $1.387B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets